- Home
- AUUD vs VRAX Comparison
AUUD vs VRAX Comparison
Compare AUUD & VRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUUD
- VRAX
- Stock Information
- Founded
- AUUD 2012
- VRAX 2013
- Country
- AUUD United States
- VRAX United Kingdom
- Employees
- AUUD N/A
- VRAX N/A
- Industry
- AUUD Computer Software: Prepackaged Software
- VRAX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- AUUD Technology
- VRAX Health Care
- Exchange
- AUUD Nasdaq
- VRAX Nasdaq
- Market Cap
- AUUD 4.2M
- VRAX 4.4M
- IPO Year
- AUUD 2021
- VRAX 2022
- Fundamental
- Price
- AUUD $2.05
- VRAX $0.62
- Analyst Decision
- AUUD
- VRAX Strong Buy
- Analyst Count
- AUUD 0
- VRAX 1
- Target Price
- AUUD N/A
- VRAX $3.00
- AVG Volume (30 Days)
- AUUD 2.9M
- VRAX 1.6M
- Earning Date
- AUUD 11-06-2025
- VRAX 01-01-0001
- Dividend Yield
- AUUD N/A
- VRAX N/A
- EPS Growth
- AUUD N/A
- VRAX N/A
- EPS
- AUUD N/A
- VRAX N/A
- Revenue
- AUUD N/A
- VRAX $6,331.00
- Revenue This Year
- AUUD N/A
- VRAX $217,274.83
- Revenue Next Year
- AUUD N/A
- VRAX N/A
- P/E Ratio
- AUUD N/A
- VRAX N/A
- Revenue Growth
- AUUD N/A
- VRAX N/A
- 52 Week Low
- AUUD $1.85
- VRAX $0.52
- 52 Week High
- AUUD $14.60
- VRAX $3.62
- Technical
- Relative Strength Index (RSI)
- AUUD 38.35
- VRAX 41.96
- Support Level
- AUUD $2.00
- VRAX $0.59
- Resistance Level
- AUUD $2.11
- VRAX $0.70
- Average True Range (ATR)
- AUUD 0.13
- VRAX 0.05
- MACD
- AUUD 0.06
- VRAX 0.01
- Stochastic Oscillator
- AUUD 40.00
- VRAX 53.48
About AUUD Auddia Inc.
Auddia Inc is a technology company that is engaged in radio broadcasts and streaming audio content digitally. Its products includes Auddia App which is a subscription-based commercial-free AM/FM software application, and Vodacast an interactive podcasting platform and application. The company generates revenue through subscription fees from customers accessing the company's cloud-based computing services and advertisement services.
About VRAX Virax Biolabs Group Limited
Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against world-wide viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes (HSV-1) and Human Papillomavirus (HPV).